• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞舒伐他汀临时配制口服混悬液的稳定性。

Stability of extemporaneously prepared rosuvastatin oral suspension.

作者信息

Zaid Abdel Naser, Shtayah Rania, Qadumi Ayman, Ghanem Mashour, Qedan Rawan, Daibes Marah, Awwad Somud Abu, Jaradat Nidal, Kittana Naim

机构信息

Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.

Department of Research and Development, Pharmacare Ltd., Ramallah, Palestine.

出版信息

Am J Health Syst Pharm. 2017 Oct 1;74(19):1579-1583. doi: 10.2146/ajhp160235.

DOI:10.2146/ajhp160235
PMID:28947528
Abstract

PURPOSE

The stability of an extemporaneously prepared rosuvastatin suspension stored over 30 days under various storage conditions was evaluated.

METHODS

Rosuvastatin suspension was extemporaneously prepared using commercial rosuvastatin tablets as the source of active pharmaceutical ingredient. The organoleptic properties, dissolution profile, and stability of the formulation were investigated. For the stability studies, samples of the suspension were stored under 2 storage conditions, room temperature (25 °C and 60% relative humidity) and accelerated stability chambers (40 °C and 75% relative humidity). Viscosity, pH, organoleptic properties, and microbial contamination were evaluated according to the approved specifications. High-performance liquid chromatography was used for the analysis and quantification of rosuvastatin in selected samples. Microbiological investigations were also conducted.

RESULTS

The prepared suspension showed acceptable organoleptic properties. It showed complete release of rosuvastatin within 15 minutes. The pH of the suspension was 9.8, which remained unchanged during the stability studies. The microbiological investigations demonstrated that the preparation was free of any microbial contamination. In addition, the suspension showed stability within at least the period of use of a 100-mL rosuvastatin bottle.

CONCLUSION

Extemporaneously prepared rosuvastatin 20-mg/mL suspension was stable for 30 days when stored at room temperature.

摘要

目的

评估临时配制的瑞舒伐他汀混悬液在不同储存条件下储存30天的稳定性。

方法

以市售瑞舒伐他汀片作为活性药物成分来源,临时配制瑞舒伐他汀混悬液。对该制剂的感官性质、溶出曲线和稳定性进行了研究。在稳定性研究中,混悬液样品分别储存在两种条件下,室温(25℃,相对湿度60%)和加速稳定性试验箱(40℃,相对湿度75%)。根据批准的规格对粘度、pH值、感官性质和微生物污染进行评估。采用高效液相色谱法对选定样品中的瑞舒伐他汀进行分析和定量。还进行了微生物学研究。

结果

所制备的混悬液具有可接受的感官性质。瑞舒伐他汀在15分钟内完全释放。混悬液的pH值为9.8,在稳定性研究期间保持不变。微生物学研究表明该制剂无任何微生物污染。此外,该混悬液在至少100 mL瑞舒伐他汀瓶的使用期内表现出稳定性。

结论

临时配制的20 mg/mL瑞舒伐他汀混悬液在室温下储存30天稳定。

相似文献

1
Stability of extemporaneously prepared rosuvastatin oral suspension.瑞舒伐他汀临时配制口服混悬液的稳定性。
Am J Health Syst Pharm. 2017 Oct 1;74(19):1579-1583. doi: 10.2146/ajhp160235.
2
Stability of an extemporaneously compounded minoxidil oral suspension.外用米诺地尔口服混悬液的稳定性。
Am J Health Syst Pharm. 2018 Mar 1;75(5):309-315. doi: 10.2146/ajhp160457.
3
Compounding and stability evaluation of atorvastatin extemporaneous oral suspension using tablets or pure powder.使用片剂或纯粉末对阿托伐他汀临时口服混悬液进行配制及稳定性评估。
Eur J Hosp Pharm. 2017 May;24(3):157-161. doi: 10.1136/ejhpharm-2016-000913. Epub 2016 Jun 15.
4
Stability of extemporaneously prepared cinacalcet oral suspensions.西那卡塞临时配制口服混悬液的稳定性
Am J Health Syst Pharm. 2018 May 1;75(9):e236-e240. doi: 10.2146/ajhp170072.
5
Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions.临时配制的苯丁酸钠口服混悬液的稳定性。
Am J Health Syst Pharm. 2007 Jul 15;64(14):1513-5. doi: 10.2146/ajhp060450.
6
Stability of extemporaneously prepared rifaximin oral suspensions.利福昔明口服混悬剂的稳定性。
Am J Health Syst Pharm. 2010 Feb 15;67(4):287-9. doi: 10.2146/ajhp090206.
7
Characterization of an extemporaneous liquid formulation of lisinopril.赖诺普利临时液体制剂的特性研究
Am J Health Syst Pharm. 2003 Jan 1;60(1):69-74. doi: 10.1093/ajhp/60.1.69.
8
Stability of an extemporaneously prepared clopidogrel oral suspension.氯吡格雷口服混悬剂的稳定性。
Am J Health Syst Pharm. 2010 Apr 1;67(7):559-61. doi: 10.2146/ajhp090163.
9
Stability of extemporaneously prepared sitagliptin phosphate solution.西他列汀磷酸盐溶液的稳定性。
PLoS One. 2022 Mar 16;17(3):e0262068. doi: 10.1371/journal.pone.0262068. eCollection 2022.
10
Stability of zonisamide in extemporaneously compounded oral suspensions.唑尼沙胺在临时配制口服混悬液中的稳定性。
Am J Health Syst Pharm. 2009 Jun 15;66(12):1105-9. doi: 10.2146/ajhp080250.

引用本文的文献

1
Tripling the Bioavailability of Rosuvastatin Calcium Through Development and Optimization of an In-Situ Forming Nanovesicular System.通过开发和优化原位形成纳米囊泡系统使瑞舒伐他汀钙的生物利用度提高两倍。
Pharmaceutics. 2019 Jun 11;11(6):275. doi: 10.3390/pharmaceutics11060275.